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In this study, poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) and poly(l-lactide) (PLA) microspheres 
containing ibuprofen were prepared with the aim of prolonging the drug release. The oil-in-water (O/W) 
emulsion solvent evaporation technique was used, varying the polymer ratio. All formulations provided 
spherical particles with drug crystals on the surface and a porous and rough polymeric matrix when 
PHBV was used and smooth external surface when prepared with PLA. The in vitro dissolution profiles 
show that the formulation containing PHBV/PLA at the proportion of 30/70 presented the best results 
in terms of prolonging the ibuprofen release. The analysis of the concentration of ibuprofen in the blood 
of rats showed that maximum levels were achieved at between one and two hours after administration 
of the immediate-release form (pure drug), while the prolonged microspheres led to a small amount 
of the drug being released within the first two hours and reached the maximum level after six hours 
of administration. It was concluded that it is possible to prolong the release of ibuprofen through its 
incorporation into PHBV/PLA microspheres.
Uniterms: Microspheres/preparation. Poly(hydroxybutyrate-co-hydroxyvalerate). Poly(l-lactide). 
Ibuprofen/release. Drugs/controlled release/in vitro study. Drugs/controlled release/in vivo evaluation.
No presente estudo foram preparadas microesferas de poli(hidroxibutirato-co-hidroxivalerato) (PHBV) 
e poli(ácido láctico) (PLA) com o objetivo de prolongar a liberação do ibuprofeno, utilizado como 
fármaco modelo. Empregou-se o método de emulsificação e evaporação do solvente óleo em água 
(O/A), variando-se a proporção entre os polímeros. Todas as formulações originaram partículas esféricas 
com cristais de fármaco aderidos à superfície externa. As microesferas apresentaram superfície rugosa 
e porosa, quando o PHBV foi utilizado, e superfície externa lisa, quando preparadas com o PLA. Os 
perfis de dissolução in vitro evidenciaram que a formulação que continha PHBV/PLA na proporção 
de 30/70 apresentou melhores resultados para prolongar a liberação do ibuprofeno. Através da análise 
da concentração de ibuprofeno no plasma de ratos, após administração oral, verificou-se que os níveis 
máximos ocorreram entre 1 e 2 horas após a administração de ibuprofeno não encapsulado, enquanto o 
fármaco presente nas microesferas atingiu um pico máximo após 6 horas da administração. Conclui-se, 
portanto, que é possível prolongar a liberação do ibuprofeno após a sua incorporação às microesferas 
preparadas com os polímeros PHBV e PLA, especialmente na proporção de 30/70.
Unitermos: Microesferas/preparação. Poli(hidroxibutirato-co-hidroxivalerato). Poli(ácido láctico). 
Ibuprofeno/liberação. Fármacos/liberação controlada/estudo in vitro. Fármacos/liberação controlada/
avaliação in vivo.
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INTRODUCTION
The incorporation of drugs into polymeric micro-
spheres can be employed in the pharmaceutical field for 
various purposes including the controlled-release of the 
drug in order to maintain therapeutic drug levels over a 
specified time period (Thompson et al., 2007). In this way 
it is possible to reduce the number of daily administrations 
of the drug and, also, to reduce the side effects.
Po lymers  such  as  po ly lac t ide  (PLA)  and 
poly(lactide-co-glycolide) (PLGA) have been success-
fully used to prepare micro- and nanoparticulate drug 
delivery systems as well as other medical devices, like 
sutures and implants (Kuo et al., 2012; Umeki et al., 
2010; Ishii et al., 2007; Sastre et al., 2007). Pharmaceu-
tical products based on PLA and PLGA microparticles 
loaded with hormones, antitumor drugs and antibiotics 
are already available in the market in Europe and the U.S. 
(Dorati et al., 2007).
The polyhydroxyalkanoates (PHAs), which are 
biodegradable and biocompatible polyesters synthesized 
by bacteria, represent another group of polymers widely 
used for pharmaceutical purposes, including microparticu-
late drug carriers. The most common PHAs are poly(3-
hydroxybutyrate) (PHB) and the related copolymer with 
3-hydroxyvalerate (PHBV). The degradation product 
of these polymers, 3-hydroxybutyric acid, is a common 
metabolite in all higher living beings indicating their non-
toxicity (Freier et al., 2002; Pouton, Akhtar, 1996). Both 
PHB and PHBV have been used to prepare micro- and 
nanoparticles containing ibuprofen (Bidone et al., 2009), 
piroxicam (Bazzo et al., 2010) and alendronate (Huang 
et al., 2009). However, in many cases, these polymers 
originate rough and porous microparticles that promote 
rapid drug release. Therefore, the association of PHAs 
with other biocompatible and biodegradable polymers like 
PLA is an interesting strategy to obtain microparticles with 
different morphological characteristics able to prolong the 
drug release.
The aim of the study reported herein was to prepare a 
microsphere system comprised of a PHBV and PLA blend 
to prolong the release of ibuprofen. This drug, a nonsteroi-
dal anti-inflammatory (NSAID), is a good candidate for 
prolonged drug release systems due its short plasmatic half 
live, which requires many daily administrations. Also, this 
drug can be taken by other routes, such as intraarticular 
administration, where a biodegradable microparticulate 
system is advantageous (Fernández-Carballido et al., 
2004). The effect of the PHBV/PLA ratio on the ibuprofen 
in vitro release from the microspheres was evaluated and 
an investigation into absorption in rats was carried out.
MATERIAL AND METHODS
Material
PHBV and PLA were kindly supplied by PHB Indus-
trial S.A. (Serrana, SP, Brazil). Ibuprofen was purchased 
from Pharma Nostra (Rio de Janeiro, RJ, Brazil) and 
poly(vinyl alcohol) from Vetec Química (Rio de Janeiro, 
RJ, Brazil). Dichloromethane, acetone, sodium hydroxide 
and hydrochloric acid were acquired from Biotec Reagen-
tes Analíticos (Pinhais, PR, Brazil) and isopropyl alcohol 
from F. Maia (Cotia, SP, Brazil). All chemicals were used 
without further purification.
Preparation of the microspheres
The microspheres were prepared through the O/W 
emulsion solvent evaporation technique. Briefly, 500 mg 
of polymer(s) and 200 mg of ibuprofen were dissolved 
in dichloromethane (internal phase) and then emulsi-
fied in 200 mL of 0.15% (w/v) PVA aqueous solution 
(external phase) containing 10 mL of isopropyl alcohol 
and acidified to pH 3.0 with HCl (1% v/v). The resulting 
emulsion was stirred at 700 rpm, at room temperature 
for 24 h until the evaporation of the organic solvent. 
The microparticles were washed with distilled water, 
centrifuged, dried and stored under vacuum at room 
temperature.
They were prepared in different formulations 
(named A, B, C and D), varying the polymer ratio, accord-
ing to Table I. Microspheres were also prepared without 
the drug according to the above-described procedure.
Loading efficiency (LE)
Approximately 10 mg of microspheres were 
weighed and dissolved in 10 mL of dichloromethane. The 
solution was diluted to give a concentration of 20.0 mg 
L-1 of ibuprofen and the UV absorption was determined 
on a Shimadzu (1601PC) UV/Vis spectrophotometer 
(l = 227 nm). The loading efficiency was calculated 
from a calibration curve prepared in the range of 5.0 and 
25.0 mg L-1.
Scanning electron microscopy (SEM)
The morphology of the microparticles was examined 
using a Philips XL30 scanning electron microscope. The 
arithmetic mean diameter of at least 100 particles was 
measured on micrographs obtained by SEM.
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In vitro drug release
The in vitro drug release was carried out in phos-
phate buffer solution pH 6.8 at 37 ± 1 oC. Approximately 
10 mg of microspheres was suspended in 45 mL of phos-
phate buffer and maintained in a thermostated oscillating 
bath for 8 hours. After pre-determined time intervals an 
aliquot of the release medium (4 mL) was withdrawn and 
the samples were immediately returned to the dissolution 
vessels after analysis. The samples were then analyzed by 
UV/Vis spectrophotometry (λ = 227 nm) and the amount 
of drug released was calculated. The percentage of drug 
release in 1 h (Q%) was used to compare the formulations 
with respect to burst release and the dissolution efficiency 
(DE) at 8 h was used to compare the prolonged drug 
release profiles. The dissolution efficiency is given by 
Equation 1. The data were evaluated by analysis of vari-
ance (ANOVA) followed by the application of the Tukey 
test, using the software GraphPad Prism®.
 
 (1)
where y denotes the percentage of dissolved drug and t 
is time.
In vivo study
Animals
Male Wistar rats (Rattus norvegicus), weighing 250-
300 g were used in this study. The animals were obtained 
from the Technological Institute of Paraná (TECPAR) and 
were maintained, six per cage, in the central bioterium 
of UNIVILLE in rooms with a dark-light cycle of 12 
hours (lights on at 7 a.m. and off at 7 p.m.) and controlled 
temperature of 20±2 oC. Animals had access to food and 
water ad libitum. All procedures involving animals were 
performed according to the national guidelines for studies 
using animals and the recommendations of the Research 
Ethics Committee of the University of Joinville. The tests 
were conducted only after approval of the procedures by 
this committee.
Experimental protocol
The animals were divided into groups of six and 
were given 0.5% carboxymethylcellulose (CMC) solution 
(0.1 mL/100 g, p.o.), ibuprofen (25 mg/kg, p.o.) or ibu-
profen microspheres (25 mg/kg, p.o.). After different time 
intervals blood samples were collected in order to evaluate 
the levels of ibuprofen. Blood was collected by punction-
ing the abdominal aorta under anesthesia with xylazine 
(10 mg/kg) and ketamine (90 mg/kg) given intraperito-
neally (Silva et al., 2010). The samples were transferred 
to heparinized tubes and centrifuged at 3000 rpm for ten 
minutes (Nova Técnica centrifuge, model NT812). The 
plasma was separated and frozen at -5 °C to be used later 
to quantify the ibuprofen levels by high performance liquid 
chromatography. Blood samples were collected one hour 
after treatment with CMC and 1, 2, 6 and 12 hours after 
administration of ibuprofen or ibuprofen microspheres, to 
observe the change in the drug levels over time.
Blood sample analysis
The plasmatic concentration of ibuprofen was de-
termined by high performance liquid chromatography 
(HPLC), using an adaptation of the methodology described 
in Li et al. (2008). Plasma (200 µL) was mixed with acetoni-
trile (700 µL) and centrifuged at 3000 rpm for 10 min. The 
supernatant was analyzed by HPLC (Merck Hitachi D7000) 
equipped with a LiChrospher® RP-18 (5 µm) column.
The mobile phase consisted of acetonitrile (A) 
and MILLI-Q® water (W) following the gradient: 1 
min (20%A/80%W), 5 min (40%A/60%W), 8 min 
(50%A/50%W), 11 min (70%A/30%W) and 15 min 
(80%A/20%W). The eluent was monitored at 220 nm with 
a flow rate of 1.0 mL min-1.
RESULTS AND DISCUSSION
Microsphere morphology and loading efficiency
The micrographs of the external surface of the micro-
spheres are presented in Figures 1 and 2. Those prepared 
without the drug (Figure 1) presented spherical shape and 
different external surface characteristics depending on 
the type of polymer used. The PLA microspheres had a 
smooth surface, as described in the literature (Umeki et 
al., 2010; Leo et al., 2000). In contrast, the microspheres 
prepared with PHBV had a rough and porous polymeric 
matrix, especially those prepared only with this polymer 
(formulation A). According to the literature, roughness 
and porosity are common characteristics of microparticles 
prepared with PHBV (Grillo et al., 2011). After the in-
corporation of ibuprofen, it was possible to observe drug 
crystals on the microsphere surfaces, especially in the case 
of formulations C and D (Figure 2).
Analysis of variance (ANOVA) shows that the 
polymer type significantly influenced the size of the micro-
spheres (p<0.05). Those prepared with PLA presented the 
smallest sizes and those prepared with PHBV the largest 
sizes, as can be seen in Table I. The microspheres prepared 
with PHBV and the PLA blend had intermediate diameters 
as expected since they were prepared using different pro-
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FIGURE 1 - Scanning electron micrographs of microspheres prepared without drug: (A) PLA; (B) PHBV; (C) PHBV/PLA 70/30; 
(D) PHBV/PLA 30/70.
FIGURE 2 - Scanning electron micrographs of ibuprofen microspheres: (A) PLA; (B) PHBV; (C) PHBV/PLA 70/30; (D) PHBV/
PLA 30/70.
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TABLE I - PHBV/PLA microsphere formulations, loading efficiency and particle diameter
Formulation PHBV/PLA ratio Loading efficiency (%) (mean ± S.D., n=3)
Particle diameter (µm) 
(mean ± S.D., n=100)
A
B
C
D
100/0
0/100
70/30
30/70
99.1 ± 3.1
80.1 ± 13.6
100.4 ± 3.4
93.6 ± 4.4
84 ± 13
49 ± 9
62 ± 8
58 ± 11
portions of both polymers. In this case, significant differ-
ences were not observed between the particle diameters 
(p>0.05), indicating that the polymer proportions (30/70 
or 70/30) did not influence the microsphere size.
High loading efficiency values were obtained for all 
microsphere formulations, as can be seen in Table I. There 
was no statistically significant difference between the LE 
values of the four formulations (p>0.05), indicating that 
the polymer ratio does not influence the LE.
In vitro drug release
The release profiles of PHBV/PLA ibuprofen mi-
crospheres are shown in Figure 3 and indicate that the 
proportion of polymers greatly influenced the drug release. 
The formulations B and D, which have a greater amount of 
PLA, showed a lower initial drug release and a prolonged 
ibuprofen release. However, those prepared with PHBV 
in a large quantity (formulations A and C) rapidly released 
almost all of the drug.
The percentages of drug release after 1 h (Q%) given 
in Figure 4 were used to evaluate the effect of polymer 
ratio on the ibuprofen initial burst release. Analysis of 
variance shows that this variable influenced the initial drug 
release (p<0.05). Through the application of the Tukey test 
it was shown that there was a significant increase in Q% 
when the proportion of PHBV in the blend was increased. 
It can be observed that formulation A showed the highest 
percentage of ibuprofen release (87.3%) and formulation 
B the lowest value (20.3%).
A factor that may have influenced the release of 
ibuprofen is the porosity of the particles along with the 
presence of drug crystals adhered to the outer surface 
of the microspheres. The rapid initial release of the drug 
(burst effect) is often undesirable in the case of prolonged 
drug release microspheres. The optimization of process 
conditions for the preparation of microspheres and also the 
development of more complex systems, such as composite 
microparticles, are strategies that can be used to reduce the 
burst release (Hassan et al., 2009). In this study, the initial 
drug release could be controlled by varying the proportion 
of polymers.
FIGURE 3 - Release profiles of PHBV/PLA/ibuprofen 
microspheres.
FIGURE 4 - Percentage of ibuprofen released (Q%) after 1 h and dissolution efficiency (DE).
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Aiming at evaluating the effect of the proportion 
of the polymers on the prolonged ibuprofen release, 
the values for the dissolution efficiency (Figure 4) were 
evaluated by analysis of variance. Significant differences 
were observed between the DE values of all formulations 
(p<0.05) except between formulations C and D (p>0.05). 
The highest values were obtained for formulation A, which 
rapidly released a large amount of drug. The porosity of 
these microspheres probably facilitated the penetration 
of the dissolution medium and, consequently, facilitated 
the ibuprofen dissolution. It has been previously reported 
that PHBV microspheres could promote the fast release of 
ibuprofen due its porosity (Wang et al., 2007).
On the other hand, the PLA microspheres (formula-
tion B) presented the lowest DE values and a delay in the 
ibuprofen release. The apparent absence of pores in these 
microspheres, which had a smooth surface, may have con-
tributed to prolonging excessively the release of ibuprofen. 
Thus, it was concluded that formulation D was the most 
appropriate to prolong the ibuprofen in vitro release for 
oral route and, therefore, this formulation was chosen for 
the in vivo assay.
In vivo study
The results for the plasmatic quantification of ibu-
profen are shown in Figure 5 and are expressed in mg L-1 
for the samples collected at each time interval.
The data show that in relation to the immediate re-
lease of ibuprofen (pure drug) there was a plasmatic peak 
at between one and two hours. After this time, there was 
a progressive decline in the drug levels. After six hours, 
around half of the maximum level was detected and, 
finally, at 12 hours after administration, the level of ibu-
profen was at its minimum. This behavior approaches the 
results obtained by Khan and Akter (2005) and Bramlage 
and Goldis (2008), who also described peak concentra-
tions of ibuprofen at between 1 and 2 hours after admin-
istration of its immediate-release form in rodents and 
humans. However, it was observed that the release profile 
of ibuprofen administered as microspheres was different 
as there was no peak in the first two hours and a higher 
concentration was found after six hours in comparison to 
the immediate-release form (pure drug). A similar decline 
in the concentration of ibuprofen incorporated in micro-
spheres was observed after 12 hours in comparison to the 
immediate-release form.
Thus, the rate of ibuprofen release from the mi-
crospheres decreased and the highest concentration of 
ibuprofen was reached after a longer period of time in 
comparison to the immediate-release form. This result 
agrees with the prediction of Ashford (2005) regarding 
drugs incorporated in microspheres, which was the pro-
motion of the availability of the drug for adsorption in a 
gradual manner when compared to the same drug given 
in an immediate-release system.
CONCLUSIONS
The present study shows that it is possible to obtain 
microspheres with different morphological characteristics 
and high ibuprofen loading using the biodegradable poly-
mers PHBV and PLA in different ratios. The prolonging of 
the ibuprofen release was achieved when a larger amount 
of PLA was used. The formulation prepared with PHBV/
PLA in the ratio of 30/70 presented the best release pro-
file of the formulations proposed, presenting the release 
profile more suitable for sustained release systems for 
oral administration. This formulation promoted a slowed 
in vivo release within the first two hours and prolonged 
the time required to reach the highest concentration to six 
hours after administration. The gradual release of the drug 
may also contribute to generating less adverse reactions, 
since the oscillation of the drug levels around the mean 
plasmatic concentration is lower, maintaining the effect 
within the therapeutic range.
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